Navigation Links
CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) today honored The Locking Cap as one of its "Top 5 Technologies To Reduce Prescription Drug Abuse."

This small safe is the only 4-digit combination locking cap for prescription bottles on the market to prevent prescription drug abuse among unauthorized users.

The Locking Cap's inventor Joseph Simpson began his crusade to stop prescription drug abuse in high school after witnessing his brother battle addiction. Now in college, Simpson and his team are dedicated to saving lives "one cap at a time."

"Our vision is to stop adolescent prescription abuse before it starts," said Simpson. "Along with being a deterrent, our product helps stop denial and start conversations between parents and kids."

The Top 5 Technologies competition aims to increase awareness of the prescription abuse epidemic, and support private-sector efforts addressing this problem.

CLAAD spokesman Michael Barnes stated, "The Locking Cap answers our organization's call for new products to foster safe medication storage and prevent kids from experimenting with prescription drugs."  

Millennium Laboratories co-sponsored the contest.  Millennium provides medication monitoring, detection and testing services.

"We are proud to recognize The Locking Cap for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Millennium Laboratories President Howard Appel. 

About the Center for Lawful Access and Abuse Deterrence

The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care.  CLAAD's National Prescription Drug Abuse Prevention Strategy, which has earned the endorsements of 30 non-profit organizations, identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition

About Millennium Laboratories

Millennium Laboratories (http://millenniumlabs.com/) is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About The Locking Cap

Prescription drug abuse is a serious public health problem that is rapidly becoming a global epidemic. The Locking Cap was created to protect families and prevent prescription drug abuse and overdoses. http://www.TheLockingCap.com, @The_Locking_Cap.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
2. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Warns of Increase in Prescription Drug Overdoses
5. MinuteClinic Recognizes National Nurse Practitioner Week and Invests in the Education and Advancement of Clinicians Across the U.S.
6. CareFusion Recognizes Best Of The Best U.S. Hospitals
7. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
8. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
9. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
10. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
11. Veteran-Owned Wiley X,® Inc. Recognizes Americas Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Obstetrics Partnering 2010-2016: Deal ... to their offering. --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ... "Global Obstetrics Partnering 2010-2016: Deal trends, ... their offering. --> Research and ...
(Date:2/4/2016)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, announced today that it has ... Morgan Stanley & Co. LLC to repurchase $325 million ... the Company,s previously authorized program to repurchase up to ... --> --> Under the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
Breaking Medicine News(10 mins):